Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1998
04/15/1998CN1179156A Indole derivatives as 5 -HT receptor antagonist
04/15/1998CN1179155A Heterocyclic compounds
04/15/1998CN1179151A Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
04/15/1998CN1179106A Recombinant human alpha-fetoprotein and uses thereof
04/15/1998CN1179104A Method of treating or preventing non-viral microbial infection
04/15/1998CN1179103A Prilocaine and hydrofluorocarbon aerosol preparations
04/15/1998CN1179102A Oral 2 -methyl -thieno -benzodiazepine formulation
04/15/1998CN1179100A Valaciclovir bablets containing colloidal silicon dioxide
04/15/1998CN1178837A Fermentation method for preparing acabose by osmosis control
04/15/1998CN1178799A Method for extracting solomonscal polyose from Chinese drug solomonseal rhizome
04/15/1998CN1178793A Bryostatin as anti-cancer active compound
04/15/1998CN1178789A Xanthene and arcridine derivative and its use
04/15/1998CN1178788A Angiotensin invertase inhibitor contaiing 2 ,4 -methylene proline and its sythesis and use
04/15/1998CN1178701A Oral liquid curing AIDS and its preparing method
04/15/1998CN1178700A Formula for new uraemia medicine and using method
04/15/1998CN1178672A Use of 8, 9 -dehydroestrone as estrin without influence to prolactin level
04/15/1998CN1178671A Method for preparing novel cephalosporin medicine composition containing substituted benzyloxy imino on the 7 th position
04/15/1998CN1178670A Non freeze-drying powder injection of heart disease curing medicine and preparing method
04/15/1998CN1178669A Medicine for treating diabetes and nephrosis containing rheinic acid
04/15/1998CN1178668A Cooperate therepeutic-pregnendione and estrin excitant for preventing bony defect
04/15/1998CN1038035C Preparing method for polyethylene protein conjugates
04/15/1998CN1038032C £(Benzodioxan, benzofuran or benzopyran) alkylamino| alkyl substituted guanidines and its preparing method, use and intermediate
04/14/1998US5739381 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present
04/14/1998US5739374 Processes of preparing diphenylheteroalkyl derivatives
04/14/1998US5739363 Using lithium salt of ethylenediamine or lithium amide in dimethyl sulfoxide
04/14/1998US5739359 Deacetylation; cyclizing to acetonide derivative; esterification; deprotecting
04/14/1998US5739351 Neurokinin a antagonists
04/14/1998US5739350 CC-1065 analogs
04/14/1998US5739345 Intermediate compounds in the preparation of heterocyclic compounds having anti-diabetic activity
04/14/1998US5739340 Indolizine derivatives with pharmaceutical activity
04/14/1998US5739339 Bactericides, antiprotozoa agents
04/14/1998US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants
04/14/1998US5739322 Process for preparing BIS-indolyl macrocycles
04/14/1998US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid
04/14/1998US5739307 Cell growth factors
04/14/1998US5739301 1-(2'-hydroxy and 2'-sulfatoalkyl) glycoside
04/14/1998US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids
04/14/1998US5739171 Method for promoting animal growth
04/14/1998US5739170 Inhibitors of metazoan parasite proteases
04/14/1998US5739167 Desferrioxamine-B salts and their use as orally effective iron chelators
04/14/1998US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent
04/14/1998US5739165 Reducing sugar-free mixture of ibuprofen and phenylpropanolamine; heat and storage stability, discoloration inhibition
04/14/1998US5739164 Block metabotropic glutamate receptors
04/14/1998US5739162 Antagonist for gastrin and/or cholecystokinin b-not a-receptors; side effect reduction; antiulcer agents; opiod-enhancing analgesics; gastrointestinal disorders; anxiolytic agents
04/14/1998US5739161 Prostaglandins; diarrhea side effect reduction
04/14/1998US5739160 Cyclopentane- and -pentene-β-amino acids
04/14/1998US5739159 Medicaments for the treatment of cardiac insufficiency
04/14/1998US5739158 Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for CNS disorders
04/14/1998US5739156 Administering to reduce nonultraviolet-induced free radical damage or aging
04/14/1998US5739153 Arylpyrazole fungicides
04/14/1998US5739152 Pharmaceutical emulsion
04/14/1998US5739151 Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
04/14/1998US5739150 Piperidinyl thiacyclic derivatives
04/14/1998US5739149 Treating asthma
04/14/1998US5739148 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
04/14/1998US5739147 Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
04/14/1998US5739145 Antitussive agents
04/14/1998US5739144 Trisubstituted phenyl derivatives
04/14/1998US5739142 4-aminobenzoylguanidine derivatives
04/14/1998US5739141 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
04/14/1998US5739139 Acetaminophen and dimenhydrinate analgesics
04/14/1998US5739138 Modulators of cellular response
04/14/1998US5739137 Enzyme inhibitor treating skin disorder, hair baldness, glandular disorder and prostatic hyperplasia
04/14/1998US5739136 Intraoral dosing method of administering medicaments
04/14/1998US5739135 Inhibitors of microsomal triglyceride transfer protein and method
04/14/1998US5739134 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran, dihydrobenzodioxin, benzodioxole, dihydrobenzodioxepin, or tetrahydrobenzoxepin)carboxamide derivatives
04/14/1998US5739133 Pyridazinedione compounds useful in treating neurological disorders
04/14/1998US5739130 Treating systemic lupus erythematosis, melanoma
04/14/1998US5739124 Administering an amine-containing estratriene
04/14/1998US5739123 Phosphinic acid derivatives with metallopeptidase inhibitory activity
04/14/1998US5739120 Treatment of viral infections by administration of α- 1-(3-alkylthio-3-deoxy-2-O-acylglyceryl)!-ω 5'-(9-arabinosylpurinyl)! diphosphates or purine isosters thereof
04/14/1998US5739117 Treatment of brain disorders resulting from reduced capacity of active glucose transport through blood-brain barrier
04/14/1998US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents
04/14/1998US5739115 Sulfated maltooligosaccharides with heparin-like properties
04/14/1998US5739114 Immunosuppressive cyclolignan derivatives
04/14/1998US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity
04/14/1998US5739110 Protection of hemopoietic cells
04/14/1998US5739013 Enzymatic synthesis of 2',5'-oligoadenylate-2',3'-cyclophosphates and treatment of papillomaviruses
04/14/1998US5739008 DNA encoding a protein comprising calmodulin-and actin-binding human caldesmon peptide fragment
04/14/1998US5738875 Process for preparing solid pharmaceutical dosage forms
04/14/1998US5738873 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia
04/14/1998US5738872 Antiallergens, antihistamines; bioavailability
04/14/1998US5738871 Fat soluble nutrient, nonionic surfactant, gelatin softener
04/14/1998US5738856 Mixture of mineral oil and reaction product of a triglyceride abd phospholipid
04/14/1998US5738850 Therapeutic composition for the treatment of skin lesions and methods for its preparation
04/14/1998CA2138298C Pyridopyrimidinone antianginal agents
04/14/1998CA2123367C Anti-allergic pharmaceutical composition for ophthalmic topical administration
04/14/1998CA2066423C Compositions and methods of manufacture of oral dissolvable medicaments
04/14/1998CA2066403C Transmucosal dosage form
04/14/1998CA2015473C Triphenylmethane derivatives
04/14/1998CA2010035C Proline derivatives
04/14/1998CA1339819C 2-(pyrid-2-yl) methylthio (or methylsulfinyl)- benzimidazole derivativestheir production and use
04/14/1998CA1339818C Antiviral purine derivatives
04/10/1998CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
04/10/1998CA2217571A1 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions and methods
04/10/1998CA2217373A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods
04/10/1998CA2217235A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods
04/10/1998CA2217135A1 Benzo-b-thiophene compounds, intermediates, formulations, and methods
04/09/1998WO1998014606A1 Method for diminishing myocardial infarction using protein phosphatase inhibitors
04/09/1998WO1998014596A2 Disease associated protein tyrosine phosphatases